A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis
Covid-19 병인에서 CD47/Sirpalpha 축의 잠재적 역할
Article
[키워드] Acute kidney injury
addressed
Air-liquid interface
antibody
Antiviral
antiviral therapy
Asymptomatic
axis
binding
bronchial epithelial cells
Caco-2
Caco-2 cells
Calu
calu-3 cells
Cancer
caused
CD47
condition
contribute
contributing to
coronavirus
coronavirus SARS-CoV-2
COVID-19
COVID-19 pandemic
COVID-19 pathology
COVID-19 research
COVID-19-related complication
COVID-19-related complications
Culture
develop
diabete
diabetes
disease
elevated
epithelial cells
expression
Factor
fibrosis
fraction
group
hyperinflammation
hypertension
IAP
Immune escape
immune response
increase
indicated
individual
infected cells
infected individual
infected individuals
life-threatening
Lung fibrosis
mechanism
Mild
Monocytes
MOST
myocardial injury
Older age
Potential
primary human bronchial epithelial cells
primary human monocytes
pulmonary hypertension
Research
resulting
risk factor
role
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2-infected individual
SARS-CoV-2-infected individuals
severe COVID-19
severe disease
SIRPalpha
Small molecules
stroke
therapeutic target
vascular disease
vasoconstriction
virus-infected cells
[DOI] 10.3390/cimb43030086 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/cimb43030086 PMC 바로가기 [Article Type] Article